OMIX

A Randomized, Double-Blind, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of BAT1806 to RoActemra in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

OMIX001604

1Summary
Title A Randomized, Double-Blind, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of BAT1806 to RoActemra in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Description The primary objective of the study is to demonstrate equivalent efficacy of BAT1806 and RoActemra in subjects with rheumatoid arthritis (RA) that is inadequately controlled by methotrexate (MTX).
Organism Homo sapiens
Data Type Clinical Research data
Data Accessibility Controlled-access
BioProject PRJCA011167
Release Date 2022-08-16
Submitter Xiaofeng Zeng (xiaofeng.zeng@cstar.org.cn)
Organization Peking Union Medical College Hospital,
Submission Date 2022-08-12
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX001604-01 Central laboratory data 3 Clinical Research data 63.1 MB zip 0 Controlled
OMIX001604-02 Scale date 1 Clinical Research data 30.0 MB xlsx 0 Controlled

Request for this Data View All Released Data of OMIX